메뉴 건너뛰기




Volumn 55, Issue 6, 2014, Pages 1087-1097

The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis

Author keywords

Fatty acid elongase 6; Hepatic steatosis; Insulin like growth factor 2 signalling; Sterol regulatory element binding transcription factor 1

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; FATTY ACID ELONGASE 6; FATTY ACID SYNTHASE; MEMBRANE ENZYME; MESSENGER RNA; PALMITOYL COENZYME A; PROTEIN P62; SMALL INTERFERING RNA; SOMATOMEDIN B; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NR1H3; UNCLASSIFIED DRUG; ACYLTRANSFERASE; FATTY ACID; FATTY ACID ELONGASES; IGF2 PROTEIN, MOUSE; IGF2BP2 PROTEIN, MOUSE; RNA BINDING PROTEIN; SREBF1 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84901649725     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M045500     Document Type: Article
Times cited : (42)

References (73)
  • 1
    • 40849083460 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease: The mist gradually clears
    • de Alwis, N. M., and C. P. Day. 2008. Non-alcoholic fatty liver disease: the mist gradually clears. J. Hepatol. 48 ( Suppl 1 ): S104-S112.
    • (2008) J. Hepatol. , vol.48 , Issue.SUPPL. 1
    • De Alwis, N.M.1    Day, C.P.2
  • 2
    • 66349125337 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease
    • Erickson, S. K. 2009. Nonalcoholic fatty liver disease. J. Lipid Res. 50 ( Suppl ): S412-S416.
    • (2009) J. Lipid Res. , vol.50 , Issue.SUPPL.
    • Erickson, S.K.1
  • 3
    • 65449156905 scopus 로고    scopus 로고
    • NAFLD as a r isk factor for the development of diabetes and the metabolic syndrome: An eleven-year follow-up study
    • Adams, L. A., O. R. Waters, M. W. Knuiman, R. R. Elliott, and J. K. Olynyk. 2009. NAFLD as a r isk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am. J. Gastroenterol. 104: 861-867.
    • (2009) Am. J. Gastroenterol. , vol.104 , pp. 861-867
    • Adams, L.A.1    Waters, O.R.2    Knuiman, M.W.3    Elliott, R.R.4    Olynyk, J.K.5
  • 4
    • 17444417085 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease
    • Adams, L. A., P. Angulo, and K. D. Lindor. 2005. Nonalcoholic fatty liver disease. CMAJ. 172: 899-905.
    • (2005) CMAJ. , vol.172 , pp. 899-905
    • Adams, L.A.1    Angulo, P.2    Lindor, K.D.3
  • 5
    • 0037129380 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease
    • Angulo, P. 2002. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346: 1221-1231.
    • (2002) N. Engl. J. Med. , vol.346 , pp. 1221-1231
    • Angulo, P.1
  • 6
    • 30044431801 scopus 로고    scopus 로고
    • From fat to infl ammation
    • Day, C. P. 2006. From fat to infl ammation. Gastroenterology. 130: 207-210.
    • (2006) Gastroenterology. , vol.130 , pp. 207-210
    • Day, C.P.1
  • 7
    • 56649094325 scopus 로고    scopus 로고
    • Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease
    • Malhi, H., and G. J. Gores. 2008. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin. Liver Dis. 28: 360-369.
    • (2008) Semin. Liver Dis. , vol.28 , pp. 360-369
    • Malhi, H.1    Gores, G.J.2
  • 8
    • 57649214103 scopus 로고    scopus 로고
    • Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD
    • Musso, G., R. Gambino, and M. Cassader. 2009. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog. Lipid Res. 48: 1-26.
    • (2009) Prog. Lipid Res. , vol.48 , pp. 1-26
    • Musso, G.1    Gambino, R.2    Cassader, M.3
  • 9
    • 51449106076 scopus 로고    scopus 로고
    • ChREBP: A glucose-activated transcription factor involved in the development of metabolic syndrome
    • Iizuka, K., and Y. Horikawa. 2008. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Endocr. J. 55: 617-624.
    • (2008) Endocr. J. , vol.55 , pp. 617-624
    • Iizuka, K.1    Horikawa, Y.2
  • 10
    • 33644652183 scopus 로고    scopus 로고
    • Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis
    • Lefebvre, P., G. Chinetti, J. C. Fruchart, and B. Staels. 2006. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J. Clin. Invest. 116: 571-580.
    • (2006) J. Clin. Invest. , vol.116 , pp. 571-580
    • Lefebvre, P.1    Chinetti, G.2    Fruchart, J.C.3    Staels, B.4
  • 11
    • 66349099340 scopus 로고    scopus 로고
    • Fatty acid metabo lism: Target for metabolic syndrome
    • Wakil, S. J., and L. A. Abu-Elheiga. 2009. Fatty acid metabo lism: target for metabolic syndrome. J. Lipid Res. 50 ( Suppl ): S138-S143.
    • (2009) J. Lipid Res. , vol.50 , Issue.SUPPL.
    • Wakil, S.J.1    Abu-Elheiga, L.A.2
  • 15
    • 79951682747 scopus 로고    scopus 로고
    • Pathogenesis of lipid metabolism disorder in hepatitis C: Polyunsaturated fatty acids counteract lipid alterations induced by the core protein
    • Miyoshi, H., K. Moriya, T. Tsutsumi, S. Shinzawa, H. Fujie, Y. Shintani, H. Fujinaga, K. Goto, T. Todoroki, T. Suzuki, et al. 2011. Pathogenesis of lipid metabolism disorder in hepatitis C: polyunsaturated fatty acids counteract lipid alterations induced by the core protein. J. Hepatol. 54: 432-43 8.
    • (2011) J. Hepatol , vol.54 , pp. 432-438
    • Miyoshi, H.1    Moriya, K.2    Tsutsumi, T.3    Shinzawa, S.4    Fujie, H.5    Shintani, Y.6    Fujinaga, H.7    Goto, K.8    Todoroki, T.9    Suzuki, T.10
  • 21
    • 84881454013 scopus 로고    scopus 로고
    • Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma
    • Muir, K., A. Hazim, Y. He, M. Peyressatre, D. Y. Kim, X. Song, and L. Beretta. 2013. Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. Cancer Res. 73: 4722-4731.
    • (2013) Cancer Res. , vol.73 , pp. 4722-4731
    • Muir, K.1    Hazim, A.2    He, Y.3    Peyressatre, M.4    Kim, D.Y.5    Song, X.6    Beretta, L.7
  • 23
    • 84898766063 scopus 로고    scopus 로고
    • Lipid metabolism signatures in NASH-associated HCC-letter
    • Epub ahead of print. April 28 doi:10.115 8/0008-5472.CAN-13-2852
    • Kessler, S. M., S. Laggai, A. Barghash, V. Helms, and A. K. Kiemer. Lipid metabolism signatures in NASH-associated HCC-letter. Cancer Res. Epub ahead of print. April 28, 2014; doi:10.115 8/0008-5472.CAN-13-2852.
    • (2014) Cancer Res
    • Kessler, S.M.1    Laggai, S.2    Barghash, A.3    Helms, V.4    Kiemer, A.K.5
  • 25
    • 84897969932 scopus 로고    scopus 로고
    • The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62/IGF2BP2-2 as a promoter of NAFLD and HCC
    • Simon, Y., S. M. Kessler, R. M. Bohle, J. Haybaeck, and A. K. Kiemer. 2014. The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62/IGF2BP2-2 as a promoter of NAFLD and HCC Gut. 63: 861-863.
    • (2014) Gut. , vol.63 , pp. 861-863
    • Simon, Y.1    Kessler, S.M.2    Bohle, R.M.3    Haybaeck, J.4    Kiemer, A.K.5
  • 26
    • 84887323587 scopus 로고    scopus 로고
    • Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH
    • Laggai, S., Y. Simon, T. Ranssweiler, A. K. Kiemer, and S. M. Kessler. 2013. Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH. World J. Hepatol. 5: 558-567.
    • (2013) World J. Hepatol. , vol.5 , pp. 558-567
    • Laggai, S.1    Simon, Y.2    Ranssweiler, T.3    Kiemer, A.K.4    Kessler, S.M.5
  • 27
    • 84874095808 scopus 로고    scopus 로고
    • IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: Antiapoptotic action is independent of IGF2/PI3K signaling. Am. J. Physiol. Gastrointest
    • Kessler, S. M., J. Pokorny, V. Zimmer, S. Laggai, F. Lammert, R. M. Bohle, and A. K. Kiemer. 2013. IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 304: G328-G336.
    • (2013) Liver Physiol. , vol.304
    • Kessler, S.M.1    Pokorny, J.2    Zimmer, V.3    Laggai, S.4    Lammert, F.5    Bohle, R.M.6    Kiemer, A.K.7
  • 28
  • 29
    • 1542509671 scopus 로고    scopus 로고
    • Autoantibodies to IGF-II mRNA binding protein p62 and overexpression of p62 in human hepatocellular carcinoma
    • Zhang, J., and E. K. Chan. 2002. Autoantibodies to IGF-II mRNA binding protein p62 and overexpression of p62 in human hepatocellular carcinoma. Autoimmun. Rev. 1: 146-153.
    • (2002) Autoimmun. Rev , vol.1 , pp. 146-153
    • Zhang, J.1    Chan, E.K.2
  • 30
    • 0033526101 scopus 로고    scopus 로고
    • A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma
    • Zhang, J. Y., E. K. Chan, X. X. Peng, and E. M. Tan. 1999. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J. Exp. Med. 189: 1101-1110.
    • (1999) J. Exp. Med. , vol.189 , pp. 1101-1110
    • Zhang, J.Y.1    Chan, E.K.2    Peng, X.X.3    Tan, E.M.4
  • 33
    • 70449657762 scopus 로고    scopus 로고
    • IGF2 mRNA-binding protein 2: Biological function and putative role in type 2 diabetes
    • Christiansen J.,A. M. Kolte,T. Hansen,F. C. Nielsen,2009. IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. J. Mol. Endocrinol.,43, 187-195.
    • (2009) J. Mol. Endocrinol. , vol.43 , pp. 187-195
    • Christiansen, J.1    Kolte, A.M.2    Hansen, T.3    Nielsen, F.C.4
  • 36
    • 33748761152 scopus 로고    scopus 로고
    • 3-Hydroxy-3-methylglutaryl-coenzyme A (CoA) synthase is involved in biosynthesis of isovaleryl-CoA in the myxobacterium Myxococcus xanthus during fruiting body formation
    • Bode, H. B., M. W. Ring, G. Schwar, R. M. Kroppenstedt, D. Kaiser, and R. Muller. 2006. 3-Hydroxy-3-methylglutaryl-coenzyme A (CoA) synthase is involved in biosynthesis of isovaleryl-CoA in the myxobacterium Myxococcus xanthus during fruiting body formation. J. Bacteriol. 188 : 6524-6528.
    • (2006) J. Bacteriol. , vol.188 , pp. 6524-6528
    • Bode, H.B.1    Ring, M.W.2    Schwar, G.3    Kroppenstedt, R.M.4    Kaiser, D.5    Muller, R.6
  • 38
    • 0034283596 scopus 로고    scopus 로고
    • Insulin effects on sterol regulatory-elementbi nding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes
    • Azzout-Marniche, D., D. Becard, C. Guichard, M. Foretz, P. Ferre, and F. Foufelle. 2000. Insulin effects on sterol regulatory-elementbi nding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes. Biochem. J. 350: 389-393.
    • (2000) Biochem. J. , vol.350 , pp. 389-393
    • Azzout-Marniche, D.1    Becard, D.2    Guichard, C.3    Foretz, M.4    Ferre, P.5    Foufelle, F.6
  • 39
    • 79953042637 scopus 로고    scopus 로고
    • Down-regulation of hepatic ApoB100 expression during hot season in transition dairy cows
    • Basirico, L., P. Morera, N. Lacetera, B. Ronchi, A. Nardone, and U. Bernabucci. 2011. Down-regulation of hepatic ApoB100 expression during hot season in transition dairy cows. Livest. Sci. 137: 49-57.
    • (2011) Livest. Sci. , vol.137 , pp. 49-57
    • Basirico, L.1    Morera, P.2    Lacetera, N.3    Ronchi, B.4    Nardone, A.5    Bernabucci, U.6
  • 42
    • 84862833343 scopus 로고    scopus 로고
    • Endoplasmic reticulum stressinduced JNK activation is a critical event leading to mitochondriamediated cell death caused by-lapachone treatment
    • Lee, H., M. T. Park, B. H. Choi, E. T. Oh, M. J. Song, J. Lee, C. Kim, B. U. Lim, and H. J. Park. 2011. Endoplasmic reticulum stressinduced JNK activation is a critical event leading to mitochondriamediated cell death caused by-lapachone treatment. PLoS ONE. 6: e21533.
    • (2011) PLoS ONE. , vol.6
    • Lee, H.1    Park, M.T.2    Choi, B.H.3    Oh, E.T.4    Song, M.J.5    Lee, J.6    Kim, C.7    Lim, B.U.8    Park, H.J.9
  • 43
    • 67349210047 scopus 로고    scopus 로고
    • Unsaturated fatty acids promote hepatoma proliferation and progression through downregula tion of the tumor suppressor PTEN
    • Vinciguerra, M., F. Carrozzino, M. Peyrou, S. Carlone, R. Montesano, R. Benelli, and M. Foti. 2009. Unsaturated fatty acids promote hepatoma proliferation and progression through downregula tion of the tumor suppressor PTEN. J. Hepatol. 50: 1132-1141.
    • (2009) J. Hepatol. , vol.50 , pp. 1132-1141
    • Vinciguerra, M.1    Carrozzino, F.2    Peyrou, M.3    Carlone, S.4    Montesano, R.5    Benelli, R.6    Foti, M.7
  • 44
    • 84871180269 scopus 로고    scopus 로고
    • Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice
    • Tripathy, S., and D. B. Jump. 2013. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice. J. Lipid Res. 54: 71-84.
    • (2013) J. Lipid Res. , vol.54 , pp. 71-84
    • Tripathy, S.1    Jump, D.B.2
  • 45
    • 40749128979 scopus 로고    scopus 로고
    • IGF2: Epigenetic regulation and role in development and disease
    • Chao, W., and P. A. D Amore. 2008. IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev. 19: 111-120.
    • (2008) Cytokine Growth Factor Rev. , vol.19 , pp. 111-120
    • Chao, W.1    Damore, P.A.2
  • 46
    • 3843061127 scopus 로고    scopus 로고
    • Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver
    • Chen, G., G. Liang, J. Ou, J. L. Goldstein, and M. S. Brown. 2004. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in live r. Proc. Natl. Acad. Sci. USA. 101: 11245-11250.
    • (2004) Proc. Natl. Acad. Sci. USA , vol.101 , pp. 11245-11250
    • Chen, G.1    Liang, G.2    Ou, J.3    Goldstein, J.L.4    Brown, M.S.5
  • 47
    • 40549135297 scopus 로고    scopus 로고
    • Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: Lessons from genetically engineered mice
    • Postic, C., and J. Girard. 2008. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 118: 829-838.
    • (2008) J. Clin. Invest. , vol.118 , pp. 829-838
    • Postic, C.1    Girard, J.2
  • 48
    • 33749370739 scopus 로고    scopus 로고
    • Liver-specifi c inhibition of Ch REBP improves hepatic steatosis and insulin resistance in ob/ob mice
    • Dentin, R., F. Benhamed, I. Hainault, V. Fauveau, F. Foufelle, J. R. Dyck, J. Girard, and C. Postic. 2006. Liver-specifi c inhibition of Ch REBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes. 55: 2159-2170.
    • (2006) Diabetes. , vol.55 , pp. 2159-2170
    • Dentin, R.1    Benhamed, F.2    Hainault, I.3    Fauveau, V.4    Foufelle, F.5    Dyck, J.R.6    Girard, J.7    Postic, C.8
  • 49
    • 34548392209 scopus 로고    scopus 로고
    • Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD)
    • Ahmed, M. H., and C. D. Byrne. 2007. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). Drug Discov. Today. 12: 740-747.
    • (2007) Drug Discov. Today. , vol.12 , pp. 740-747
    • Ahmed, M.H.1    Byrne, C.D.2
  • 50
    • 0033570119 scopus 로고    scopus 로고
    • Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus
    • Shimomura, I., Y. Bashmakov, and J. D. Horton. 1999. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274: 30028-30032.
    • (1999) J. Biol. Chem. , vol.274 , pp. 30028-30032
    • Shimomura, I.1    Bashmakov, Y.2    Horton, J.D.3
  • 51
    • 34347406521 scopus 로고    scopus 로고
    • SREBP-1c transcription factor and lipid homeostasis: Clinical perspective
    • Ferré, P., and F. Foufelle. 2007. SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm. Res. 68: 72-82.
    • (2007) Horm. Res. , vol.68 , pp. 72-82
    • Ferré, P.1    Foufelle, F.2
  • 52
    • 78650043469 scopus 로고    scopus 로고
    • Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity
    • Kim, K. H., G. Y. Lee, J. I. Kim, M. Ham, J. Won Lee, and J. B. Kim. 2010. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity. J. Lipid Res. 51: 3425-3433.
    • (2010) J. Lipid Res. , vol.51 , pp. 3425-3433
    • Kim, K.H.1    Lee, G.Y.2    Kim, J.I.3    Ham, M.4    Won Lee, J.5    Kim, J.B.6
  • 55
    • 0030961960 scopus 로고    scopus 로고
    • Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells
    • Shimomura, I., H. Shimano, J. D. Horton, J. L. Goldstein, and M. S. Brown. 1997. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J. Clin. Invest. 99: 838-845.
    • (1997) J. Clin. Invest. , vol.99 , pp. 838-845
    • Shimomura, I.1    Shimano, H.2    Horton, J.D.3    Goldstein, J.L.4    Brown, M.S.5
  • 56
    • 0035852770 scopus 로고    scopus 로고
    • Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands
    • DeBose-Boyd, R. A., J. Ou, J. L. Goldstein, and M. S. Brown. 2001. Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands. Proc. Natl. Acad. Sci. USA. 98: 1477-1482.
    • (2001) Proc. Natl. Acad. Sci. USA. , vol.98 , pp. 1477-1482
    • De Bose-Boyd, R.A.1    Ou, J.2    Goldstein, J.L.3    Brown, M.S.4
  • 58
    • 42149148782 scopus 로고    scopus 로고
    • IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway
    • Smith, T. M., K. Gilliland, G. A. Clawson, and D. Thiboutot. 2008. IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway. J. Invest. Dermatol. 128: 1286-1293.
    • (2008) J. Invest. Dermatol. , vol.128 , pp. 1286-1293
    • Smith, T.M.1    Gilliland, K.2    Clawson, G.A.3    Thiboutot, D.4
  • 59
    • 33745896223 scopus 로고    scopus 로고
    • Defi ciency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-defi cient (ob/ob) mice
    • Iizuka, K., B. Miller, and K. Uyeda. 2006. Defi ciency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-defi cient (ob/ob) mice. Am. J. Physiol. Endocrino l. Metab. 291: E358-E364.
    • (2006) Am. J. Physiol. Endocrino L. Metab. , vol.291
    • Iizuka, K.1    Miller, B.2    Uyeda, K.3
  • 60
    • 84893451810 scopus 로고    scopus 로고
    • ChREBP, a glucoseresponsive transcriptional factor, enhances glucose metabolism to support biosynthesis in human cytomegalovir us-infected cells
    • Yu, Y., T. G. Maguire, and J. C. Alwine. 2014. ChREBP, a glucoseresponsive transcriptional factor, enhances glucose metabolism to support biosynthesis in human cytomegalovir us-infected cells. Proc. Natl. Acad. Sci. USA. 111: 1951-1956.
    • (2014) Proc. Natl. Acad. Sci. USA , vol.111 , pp. 1951-1956
    • Yu, Y.1    Maguire, T.G.2    Alwine, J.C.3
  • 63
    • 18244382304 scopus 로고    scopus 로고
    • Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
    • Donnelly, K. L., C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt, and E. J. Parks. 2005. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115: 1343-1351.
    • (2005) J. Clin. Invest. , vol.115 , pp. 1343-1351
    • Donnelly, K.L.1    Smith, C.I.2    Schwarzenberg, S.J.3    Jessurun, J.4    Boldt, M.D.5    Parks, E.J.6
  • 66
    • 33646812161 scopus 로고    scopus 로고
    • Fenofi brate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver
    • Harano, Y., K. Yasui, T. Toyama, T. Nakajima, H. Mitsuyoshi, M. Mimani, T. Hirasawa, Y. Itoh, and T. Okanoue. 2006. Fenofi brate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver. Liver Int. 26: 613-620.
    • (2006) Liver Int. , vol.26 , pp. 613-620
    • Harano, Y.1    Yasui, K.2    Toyama, T.3    Nakajima, T.4    Mitsuyoshi, H.5    Mimani, M.6    Hirasawa, T.7    Itoh, Y.8    Okanoue, T.9
  • 67
    • 0034806134 scopus 로고    scopus 로고
    • Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoAinduced inhibition of fatty acid oxidation and cytotoxicity
    • Thupari , J. N., M. L. Pinn, and F. P. Kuhajda. 2001. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoAinduced inhibition of fatty acid oxidation and cytotoxicity. Biochem. Biophys. Res. Commun. 285: 217- 223.
    • (2001) Biochem. Biophys. Res. Commun. , vol.285 , pp. 217-223
    • Thupari, J.N.1    Pinn, M.L.2    Kuhajda, F.P.3
  • 68
    • 43249086785 scopus 로고    scopus 로고
    • Mammalian long-chain acyl-CoA synthetases
    • Soupene, E., and F. A. Kuypers. 2008. Mammalian long-chain acyl-CoA synthetases. Exp. Biol. Med. (Maywood). 233: 507-521.
    • (2008) Exp. Biol. Med. (Maywood , vol.233 , pp. 507-521
    • Soupene, E.1    Kuypers, F.A.2
  • 69
    • 0025237826 scopus 로고
    • Acute hormonal control of acetyl-CoA carboxylase. The roles of insulin, glucagon, and epinephrine
    • Mabrouk, G. M., I. M. Helmy, K. G. Thampy, and S. J. Wakil. 1990. Acute hormonal control of acetyl-CoA carboxylase. The roles of insulin, glucagon, and epinephrine. J. Biol. Chem. 265: 6330-6338.
    • (1990) J. Biol. Chem. , vol.265 , pp. 6330-6338
    • Mabrouk, G.M.1    Helmy, I.M.2    Thampy, K.G.3    Wakil, S.J.4
  • 70
    • 0031043030 scopus 로고    scopus 로고
    • The mitochondrial carnitine palmitoyltransferase system. from concept to molecular analysis
    • McGarry, J. D., and N. F. Brown. 1997. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem. 244: 1-14.
    • (1997) Eur. J. Biochem. , vol.244 , pp. 1-14
    • Mc Garry, J.D.1    Brown, N.F.2
  • 71
    • 54049150442 scopus 로고    scopus 로고
    • Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis
    • Anderson, N., and J. Borlak. 2008. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacol. Rev. 60: 311-357.
    • (2008) Pharmacol. Rev. , vol.60 , pp. 311-357
    • Anderson, N.1    Borlak, J.2
  • 72
  • 73
    • 21744460524 scopus 로고    scopus 로고
    • Transcrip t and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis
    • Lelliott, C. J., M. Lopez, R. K. Curtis, N. Parker, M. Laudes, G. Yeo, M. Jimenez-Linan, J. Grosse, A. K. Saha, D. Wiggins, et al. 2005. Transcrip t and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis. FASEB J. 19: 1108-1119.
    • (2005) FASEB J. , vol.19 , pp. 1108-1119
    • Lelliott, C.J.1    Lopez, M.2    Curtis, R.K.3    Parker, N.4    Laudes, M.5    Yeo, G.6    Jimenez-Linan, M.7    Grosse, J.8    Saha, A.K.9    Wiggins, D.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.